Full text is available at the source.
Abstract
Patients receiving armodafinil showed significant improvements in late-in-shift clinical condition, wakefulness, and overall functioning compared to placebo.
- Armodafinil may reduce sleepiness experienced by patients with shift work disorder during late-night shifts.
- Improvements were observed in clinical condition as measured by Clinical Global Impression-Change.
- Overall functioning of patients, assessed by the Global Assessment of Functioning score, was also enhanced.
- Armodafinil was generally well tolerated among participants in the study.
Simplified